Jessica Caroline Chutter - 24 Mar 2026 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Reporting relationship: Director
Issuer ticker: PTCT
Reported as of: 24 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Mar 2026, 19:41:34 UTC
Next SEC filing: 10 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Avraham S. Adler, Attorney-in-Fact

Key filing fact

Jessica Caroline Chutter filed Form 4 for PTC THERAPEUTICS, INC. (PTCT) on 26 Mar 2026.

Key facts

This page summarizes Jessica Caroline Chutter's Form 4 filing for PTC THERAPEUTICS, INC. (PTCT).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 26 Mar 2026, 19:41.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002123815 Primary reporting owner

Chutter Jessica Caroline

Relationship: Director
Address: C/O PTC THERAPEUTICS, INC., 500 WARREN CORPORATE CENTER DRIVE, WARREN
Signature: /s/ Avraham S. Adler, Attorney-in-Fact
Signature date: 26 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PTCT transaction

Common Stock

Award

Transaction value
Shares: +4,000
Change %
Price: $0.000000^*
Shares after: 4,000
Date: 24 Mar 2026
Ownership: Direct
Footnotes: F1

PTCT transaction

Common Stock

Award

Transaction value
Shares: +3,333
Change %: +83%
Price: $0.000000^*
Shares after: 7,333
Date: 24 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PTCT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +3,475
Change %
Price: $0.000000^*
Shares after: 3,475
Date: 24 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,475
Exercise price: $64.54
Footnotes: F3

PTCT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +2,896
Change %
Price: $0.000000^*
Shares after: 2,896
Date: 24 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,896
Exercise price: $64.54
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Restricted stock units granted on March 24, 2026 that vest in three equal annual installments, commencing on March 24, 2027.

Footnote F2

Restricted stock units granted on March 24, 2026 that vest with respect to 1,000 shares underlying such restricted stock units on June 2, 2026, and with respect to the remaining 2,333 shares on January 2, 2027.

Footnote F3

This option was granted on March 24, 2026 and vests over 36 equal monthly installments, commencing on April 24, 2026.

Footnote F4

This option was granted on March 24, 2026 and vests over 10 equal monthly installments, commencing on April 2, 2026.